Adolore Biotherapeutics, Inc. | WebDisclosure

Switch to English

10238	Sociétés
211363	Mots-clés
141296	Articles
111973	Communiqués

Accueil
Sociétés
Adolore Biotherapeutics, Inc.

COMMUNIQUÉ DE PRESSE

publié le 16/05/2024 à 16:00, il y a 1 année 11 mois

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années 1 mois

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années 1 mois

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
COMMUNIQUÉ DE PRESSE

publié le 04/03/2024 à 16:00, il y a 2 années 1 mois

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
COMMUNIQUÉ DE PRESSE

publié le 30/01/2024 à 16:00, il y a 2 années 2 mois

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 16:30, il y a 2 années 4 mois

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
COMMUNIQUÉ DE PRESSE

publié le 11/10/2023 à 16:00, il y a 2 années 6 mois

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
COMMUNIQUÉ DE PRESSE

publié le 03/10/2023 à 15:15, il y a 2 années 6 mois

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Les Echos

Publié le 17/04/2026 à 20:30, il y a 1 jour 9 heures

ALTAREA - Déclaration d’opérations sur actions propres
Publié le 17/04/2026 à 19:00, il y a 1 jour 11 heures

Cegedim : Publication du Document d’Enregistrement Universel 2025
Publié le 17/04/2026 à 19:00, il y a 1 jour 11 heures

Cegedim: Release of its 2025 Universal Registration Document
Publié le 17/04/2026 à 17:45, il y a 1 jour 12 heures

Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Publié le 17/04/2026 à 17:45, il y a 1 jour 12 heures

Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 18/04/2026 à 04:00, il y a 1 jour 2 heures

Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Publié le 18/04/2026 à 02:00, il y a 1 jour 4 heures

AI/ML Innovations Announces Completion of Share Issuance
Publié le 18/04/2026 à 01:35, il y a 1 jour 4 heures

Medicure Announces Resignation of President and Chief Operating Officer
Publié le 18/04/2026 à 01:00, il y a 1 jour 5 heures

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Publié le 18/04/2026 à 00:00, il y a 1 jour 6 heures

Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia

Voir tout ACCESSWIRE

EQS Group

Publié le 18/04/2026 à 00:05, il y a 1 jour 6 heures

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Publié le 17/04/2026 à 21:39, il y a 1 jour 8 heures

Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Publié le 17/04/2026 à 20:33, il y a 1 jour 9 heures

LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Publié le 17/04/2026 à 19:35, il y a 1 jour 10 heures

Stabilisation Notice
Publié le 17/04/2026 à 19:30, il y a 1 jour 10 heures

KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS